Mark Lundie

Director/Board Member at Clinical Trials Ontario

Finance

Commercial Services

Health Technology

Profile

Mark Lundie is currently serving as a Board of Director at Ontario Genomics Institute (Private Equity) and as a Director at Clinical Trials Ontario.
He previously worked as the Chairman at Centre For Probe Development & Commercialization.

Mark Lundie active positions

Companies	Position	Start
Clinical Trials Ontario Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada.	Director/Board Member	-
Ontario Genomics Institute (Private Equity) Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.	Director/Board Member	-

All active positions of Mark Lundie

Former positions of Mark Lundie

Companies	Position	End
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Chairman	-

See the detail of Mark Lundie's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Lundie's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Ontario Genomics Institute (Private Equity) Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.	Finance
Clinical Trials Ontario Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada.	Commercial Services
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Health Technology

See company connections